Has Vernon Horst, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,439 in general payments to Vernon Horst, MD across 89 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vernon Horst, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vernon Horst, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vernon Horst, MD

Vascular Surgery · Birmingham, ALNPI 1033478466

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.7%), charitable contributions and grants — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $5,355 and has fallen 83.5% since, to $885 in 2025.

$9,439in general payments, 2019–2025

Across 89 payments — averaging $106.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$6K
Silk Road Medical, Inc.$1K
W. L. Gore & Associates, Inc.$587
Penumbra, Inc.$328
Boston Scientific$315
Endologix LLC$312
plus $914 from 15 others

What the payments were for

Grants$2,25024%
Food & beverage$4,49848%
Education$1912%
Charitable contribution$2,50026%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	18	$5,682
Silk Road Medical, Inc.	22	$1,301
W. L. Gore & Associates, Inc.	10	$587
Penumbra, Inc.	3	$328
Boston Scientific	10	$315
Endologix LLC	2	$312
Inari Medical, Inc.	5	$223
Veryan Medical Incorporated	2	$140
Solventum Corporation	1	$121
Stryker	2	$75
Artivion, Inc.	1	$55
Bolton Medical Inc	1	$47
Convatec Inc.	2	$45
Kerecis Limited	2	$41
Lemaitre Vascular, Inc.	2	$33
KCI USA, Inc.	1	$29
Teleflex LLC	1	$29
Bard Peripheral Vascular, Inc.	1	$25
Tactile Systems Technology Inc	1	$23
Urgo Medical North America, LLC	1	$16
Shockwave Medical, Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Endurant$4,967
ENROUTE Transcarotid Neuroprotection System$770
ENROUTE Transcarotid Stent$615
Penumbra System$304
GORE VIABAHN VBX Balloon Expandable Endo$192
Alto Abdominal Stent Graft System$183
EXCLUDER Conformable AAA Endoprosthesis with Active Control$157
ENROUTE Transcarotid Stent System$156
ENHANCE Transcarotid Peripheral Access Kit$156
ENROUTE 0.014 Guidewire$156
ELUVIA$136
ENDOCROSS Device$129
Torus Stent Graft System$129
BioMimics 3D Vascular Stent System$125
PREVENA$121
V.A.C. VERAFLO$121
V.A.C. ULTA$121
Heli-FX EndoAnchor System$110

How this compares

$9,439 in reported general payments places this provider in the 65th percentile of 61 vascular surgery providers in Alabama.

See all vascular surgery providers in Alabama →

Medicare billing

Part B allowed, 2024

$57,054

Medicare patients

Services billed

300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	24	$15,064
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	65	$472
Cilostazol	25	$449
ClopidogrelClopidogrel Bisulfate	17	$131
Atorvastatin Calcium	15	$117

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Birmingham

Albert PacificoBirmingham$5.1M
Benjamin PearceBirmingham$37K
William HolmanBirmingham$25K
Stephen HeinzmanBirmingham$18K
Jarrad RowseBirmingham$10K
Graeme McFarlandBirmingham$10K
James KirklinBirmingham$6K
Danielle SutzkoBirmingham$5K
Mark PattersonBirmingham$5K
Michael GleasonBirmingham$3K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →